Role of Semaphorin Signaling During Cardiovascular Development.

Abstract

HomeJournal of the American Heart AssociationVol. 7, No. 11Role of Semaphorin Signaling During Cardiovascular Development Open AccessReview ArticlePDF/EPUBAboutView PDFView EPUBSections ToolsAdd to favoritesDownload citationsTrack citations ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toOpen AccessReview ArticlePDF/EPUBRole of Semaphorin Signaling During Cardiovascular Development Qianchuang Sun, MD, Shuyan Liu, MD, Kexiang Liu, MD and Kai Jiao, MD, PhD Qianchuang SunQianchuang Sun Department of Anesthesiology, The Second Hospital of Jilin University, Changchun, China Department of Genetics, The University of Alabama at Birmingham, AL Search for more papers by this author , Shuyan LiuShuyan Liu Department of Ophthalmology, The Second Hospital of Jilin University, Changchun, China Department of Genetics, The University of Alabama at Birmingham, AL Search for more papers by this author , Kexiang LiuKexiang Liu Department of Cardiovascular Surgery, The Second Hospital of Jilin University, Changchun, China Search for more papers by this author and Kai JiaoKai Jiao Department of Genetics, The University of Alabama at Birmingham, AL Search for more papers by this author Originally published18 May 2018https://doi.org/10.1161/JAHA.118.008853Journal of the American Heart Association. 2018;7:e008853Semaphorins are a family of secreted and membrane‐bound molecules that play critical functions in diverse biological processes.1, 2, 3, 4, 5, 6, 7, 8, 9 SEMA1A/Fasciclin IV is the founding member of the semaphorin family and was first reported in 1992 as a regulator of axon branching in the growth cone of grasshopper embryos.10 To date, more than 20 semaphorin members have been discovered in viruses, invertebrates, and vertebrates.3, 5, 11 In addition to acting as guidance cues for axon growth in the nervous system, semaphorins have been implicated in many other systems, such as immune responses, tumor angiogenesis, bone development and homeostasis, and cardiovascular development.1, 2, 3, 4, 5, 6, 7, 8, 9Semaphorins are categorized into 8 classes. Classes 1 and 2 are found in invertebrates, classes 3 to 7 are present in vertebrates, and class V semaphorins are found only in viruses.3, 12 All semaphorins contain a conserved domain of about 500 amino acids, termed the sema domain, which is located close to the N‐terminal end of the molecule13 (Figure 1). Crystal structures have revealed that the sema domain is composed of a 7‐bladed β‐propeller fold, arranged radially around a central axis. Each blade comprises a 4‐strand antiparallel β‐sheet.14, 15 With the exception of certain poxvirus semaphorins, other viral and all animal semaphorins contain a plexin‐semaphorin‐integrin domain in their extracellular regions, immediately to the C‐terminal of the sema domain.12, 16, 17 The plexin‐semaphorin‐integrin domain is a disulfide‐rich motif that is found in plexins, semaphorins, and integrins. In addition to the defined sema and plexin‐semaphorin‐integrin domains, semaphorins can be further distinguished by other specific additional motifs (Figure 1). For instance, classes 2, 3, 4, and 7 contain an immunoglobulin‐like domain, class 5 members contain 7 thrombospondin type 1 repeats, and class 3 members contain a basic domain. Some class V members contain an immunoglobulin‐like domain, but others do not.3, 12, 16 Semaphorins can be membrane anchored or secreted. Classes 1, 4, 5, and 6 are transmembrane proteins, whereas classes 2, 3, and V are secreted proteins. Class 7 proteins are glycosylphosphatidylinositol‐linked proteins.3, 11 Some transmembrane semaphorins, such as SEMA6D, also have secreted forms to act both locally and over a long distance.18, 19Download PowerPointFigure 1. Semaphorins and plexins contain multiple functional domains. Plexins are the primary receptors for semaphorins20, 21, 22 (Table 1). They are segregated into 4 subfamilies, including PLXNA1‐4, PLXNB1‐3, PLXNC, and PLXND.2, 6, 12, 23, 24 Similar to semaphorins, all plexins contain a sema domain at their N‐terminal ends (Figure 1). The extracellular domains of plexins also contain 3 plexin‐semaphorin‐integrin motifs and 3 to 6 immunoglobulin‐like plexin transcription factors domains. On the intracellular side, plexins are comprised of a rho GTPase‐binding domain and a segment GTPase‐activating protein domain.2, 6, 12, 23, 24 Recent structural studies have shown that semaphorins form a homodimer through intermolecular disulfide bridges to trigger plexin signaling. Semaphorins and plexins interact with each other through their respective sema domains in a “head‐to‐head” orientation. Two plexin molecules bind 1 semaphorin homodimer to form a bivalent 2:2 complex to mediate cell‐cell signaling. Proteolytic cleavage of the semaphorin dimer results in its dissociation to monomeric semaphorin, which can still bind plexin but fails to trigger signaling.11, 23, 25 The same semaphorin molecule can interact with different plexins, and different semaphorins can interact with the same plexins, adding to the complexity of semaphorin‐plexin signaling (Table 1). It is noteworthy that the biological activities of the semaphorin‐plexin interaction can be further modified by coreceptors. For example, class 3 semaphorins bind to neuropilin (NRP)/plexin complexes, which require NRP1 and/or NRP2 as coreceptors in the complexes.20, 21, 22 In another example, SEMA6D interacts with the PLXNA4/vascular endothelial growth factor (VEGFR2) receptor complex to stimulate endothelial cell migration in the outflow tract (OFT) region of chicken embryonic hearts, whereas interaction with the PLEXINA4/PTK7 complex inhibits endothelial cell migration in the ventricle region.18Table 1. Semaphorins and Their Corresponding Plexin Receptors2, 5, 6, 8SemaphorinsOrganismsPlexinsSEMA1AInvertebratePLXN ASEMA1BInvertebratePLXN ASEMA2BInvertebratePLXN BSEMA3AVertebratePLXN A1, A2, A3, A4, D1SEMA3BVertebratePLXN A1, A2, A3, A4SEMA3CVertebratePLXN A1, A2, B1, D1SEMA3DVertebratePLXN D1SEMA3EVertebratePLXN B2, D1SEMA3FVertebratePLXN A1, A3, A4SEMA4AVertebratePLXN B1, B2, B3, D1SEMA4BVertebratePLXN B2SEMA4CVertebratePLXN B2SEMA4DVertebratePLXN B1, B2, C1SEMA4GVertebratePLXN B2SEMA5AVertebratePLXN A1, A3, B3SEMA5BVertebratePLXN A1, A3SEMA6AVertebratePLXN A2, A4SEMA6BVertebratePLXN A1, A2, A4SEMA6CVertebratePLXN A1SEMA6DVertebratePLXN A1, D1SEMA7AVertebratePLXN C1Poxvirus A39RVirusPLXN C1Although plexins are the best‐studied semaphorin receptors, recent findings suggest that other proteins can also act as receptors by binding to the extracellular domain of semaphorins. For example, TIM2, which belongs to the Tim protein family and is characterized by expression on activated T cells and the presence of conserved immunoglobulin domain and mucin domains, is a receptor for SEMA4A.26 CD72 is a novel class of SEMA4D receptor on lymphocytes that belongs to the C‐type lectin family.27 Moreover, SEMA7A exerts an essential function by binding and stimulating monocytes through the α1β1 integrin receptor in both the nervous and immune systems.28Brief Introduction of Cardiovascular DevelopmentCardiovascular development in embryos can be subdivided into heart development and vascular development. The heart is the first functional organ formed in mammals.9, 29, 30, 31, 32 Initially, the heart develops from clusters of progenitor cells, which coalesce to form the cardiac crescent and the heart tube.31, 32, 33 Subsequently, the heart tube undergoes elongation, looping, septation, remodeling, and maturation to form the final 4‐chambered organ.31, 32, 33 Multiple cell types, including myocardial, endocardial, epicardial, and neural crest cells (NCCs) act coordinately during complicated cardiogenesis in vertebrates. NCCs are a group of pluripotent cells that are generated at the edge of neural tubes. Cardiac NCCs migrate through pharyngeal arches 3, 4, and 6 to enter the distal region of the OFT, where they play a critical role in separation of the aorta root and pulmonary trunk.34, 35, 36 Some cardiac NCCs in the OFT region eventually become interstitial cells in semilunar valves. In addition, NCCs give rise to a group of smooth muscle cells in the pharyngeal arch arteries. In the proximal region of the OFT and atrioventricular (AV) canal region, a subset of endocardial cells respond to signals released from the myocardium and undergo epithelial‐mesenchymal transition (EMT) to become cushion mesenchymal cells during midgestation. The cellularized OFT and AV cushions facilitate unidirectional blood flow in embryos and are further remodeled into mature septa and valve structures.37, 38, 39, 40, 41 Most cushion mesenchymal cells become interstitial cells in valves. Vascular development is initiated with vasculogenesis. In this process, mesoderm‐derived angioblasts form a primitive vascular plexus,42 which is further developed into a mature blood vessel system to ensure proper blood supply for the whole body.43Numerous signaling pathways and downstream transcription factors are required for normal cardiogenesis and blood vessel development.9, 31, 32, 33, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51 In the past 2 decades, accumulated studies have indicated that impaired semaphorin signaling results in various cardiovascular disorders during development and in multiple disease states. In this article we summarize recent discoveries regarding the function of semaphorins during mammalian cardiovascular development, with a primary focus on members of the SEMA3, SEMA5, and SEMA6 families, whose activities during cardiovascular development have been supported with gene inactivation studies in mice.Versatile Activities of Semaphorins During Cardiovascular DevelopmentRole of Class 3 Semaphorins During Cardiovascular DevelopmentSEMA3A Role.SEMA3A regulates cardiac innervation patterning and is essential for heart rate control.52Sema3A−/− mice lack a cardiac sympathetic innervation gradient, which leads to sinus bradycardia, abrupt sinus slowing, and stellate ganglia defects.52 In support of the direct role of SEMA3A in regulating innervation in cardiomyocytes, myocardial‐specific overexpression of Sema3A resulted in prolonged action potential duration, reduction of sympathetic innervation, and spontaneous ventricular arrhythmia.52 The role of SEMA3A in regulating sympathetic innervation is not limited to developing hearts. In a rat myocardial infarction model, overexpression of Sema3A in left stellate ganglion and myocardium reduces sympathetic reinnervation in the myocardial infarction border zone and the susceptibility to malignant arrhythmia.53, 54 In an independent gene inactivation study, the major cardiac phenotype of Sema3A homozygous mutant mice is postnatal right ventricle hypertrophy.55 The differential phenotypes reported in the literature are likely due to the specific knockout strategies and/or mouse strains used by different groups.In support of the clinical relevance of SEMA3A function in rodent cardiomyocytes, addition of SEMA3A to cardiomyocytes derived from human‐induced pluripotent stem cells inhibited the Kv4.3 (Ito) channel, as observed in heterologous human embryonic kidney cells.56 Furthermore, several missense mutations in SEMA3A (R552C, R734W, and I334V) were shown to be associated with Brugada syndrome and unexplained cardiac arrest.56, 57 These mutations impaired the ability of SEMA3A to inhibit the Kv4.3 (Ito) channel.56SEMA3A is also important for normal development of blood vessels. Knocking out Sema3A in mice led to abnormal patterning of anterior cardinal veins in the head and intersomitic vessels in the trunk region.58 The cranial blood vessels in mutants remain at the primitive capillary plexus stage and fail to remodel. The mouse vascular defects can be observed in the CD‐1 background but not in 129/Sv background, suggesting the involvement of other genetic factors in determining vascular phenotypes in Sema3A‐null mice. Severe defects in dorsal aorta development were also observed in zebrafish with sema3a either knocked down or overexpressed59; however, a similar phenotype was not reported in Sema3A mutant mice. A further mechanistic study showed that SEMA3A acts as a selective inhibitor of VEGF‐mediated angiogenesis via disruption of focal adhesion kinase/Src signaling and as a potent inducer of microvascular permeability via activation of NRP1.60SEMA3C Roles.SEMA3C/PLXNA2 signaling and SEMA3C/NRP1 signaling are required for NCC development, which is essential for proper septation of the cardiac OFT.61, 62, 63 Using NCCs isolated from Hamburger Hamilton 10 chicken embryos, Toyofuku et al found that SEMA3C promoted NCC migration through PLXND1 and NRP1.64Sema3C complete knockout mice are cyanotic and die shortly after birth from interruption of the aortic arch, persistent truncus arteriosus, and septation defects in the OFT.61 These morphological defects are likely caused by failure of NCCs to migrate into the proximal OFT.61 A recent study using a conditional gene inactivation approach indicated that SEMA3C expressed in NCCs activates NRP1 in endocardial cells of the OFT to promote EMT in OFT cushions,63 which are essential for proper OFT septation and semilunar valve formation. A recent study systematically examined the cis‐regulatory elements that control the proper expression of Sema3C in the OFT and pharyngeal arch regions.65 This group of researchers found that transcription factors FOXC1 and FOXC2 can directly bind the FOX binding sites in the enhancer region of Sema3C to promote its transcription in the OFT myocardium. In the pharyngeal arch region, expression of Sema3C is repressed by TBX1‐FGF8. This study strongly supports the idea that proper spatiotemporal expression of SEMA3C is essential for normal septation of the OFT.65SEMA3C can also regulate blood vessel formation. It inhibits VEGF‐induced endothelial cell adhesion and migration through PLXND1 and NRP1 receptors in both in vitro and in vivo assays.66 Moreover, the local administration of SEMA3C into the vitreous body of a retinopathy of prematurity model prevents the formation of pathological retinal angiogenesis.66SEMA3D Roles.Functions of SEMA3D during cardiovascular development have been found in multiple vertebrates. Knocking down expression of sema3D in zebrafish led to dysmorphic hearts with smaller ventricles, smaller atrium, and thickened myocardial wall.67 Endocardium was present in sema3D‐knockdown fish; however, AV valves and trabeculation were absent.The function of SEMA3D in mammals appears to be different from that in zebrafish. Rather, mammalian SEMA3D provides repulsive cues to direct normal endothelial cell development. In vitro analyses using primary human umbilical vascular endothelial cells showed that exogenous SEMA3D inhibits endothelial cell migration and tube formation and that this activity requires PLXND1/NRP168, 69 and activation of the PI3K/AKT pathway.68 Inactivation of Sema3D in mice led to total anomalous pulmonary venous connection in which pulmonary veins abnormally enter the coronary sinus.70 These results suggest that signals provided by SEMA3D are particularly important for endothelial cells of pulmonary veins in vivo. Sema3D‐/– mice can survive to adulthood but show severe cardiomegaly due to dilation of right atria and ventricles accompanied by left‐to‐right shunt, which is likely secondary to the total anomalous pulmonary venous connection defect.70 Furthermore, a point mutation (F602L) in SEMA3D was identified in a human patient with partial anomalous pulmonary venous connection.70In addition to the loss‐of‐function allele, a gain‐of‐function allele was also identified in a human patient who carried a duplication of the 5′ half of SEMA3D.71 This patient displayed transposition of the great arteries, ventricular septal defect, and coarctation of the aorta. The authors speculated that migration of cardiac NCCs into the OFT is impaired in patients. However, a role of SEMA3D in NCCs has not been demonstrated using animal models.SEMA3E Role.SEMA3E is a potent repulsive guidance cue for endothelial cells. Sema3E mRNA is robustly expressed in the caudal region of each somite in E11.5 mouse embryos from in situ hybridization analysis.72 Knocking out Sema3E led to disorganized intersomitic vessels, suggesting the essential role of SEMA3E in guiding intersomitic vessel formation and patterning. Further detailed examination of the Sema3E‐null mice revealed more vascular defects, including the paired dorsal aortas and fusion of a large plexus of blood vessels.73, 74 To further support SEMA3E as a repulsive cue for endothelial cells, electroporation of a SEMA3E expression plasmid into E3 chicken embryos reduced vessel formation in the area where SEMA3E was ectopically expressed.72SEMA3E appears to act primarily through PLXND1 in blood vessels. Alkaline phosphatase‐tagged SEMA3E (AP‐SEMA3E) bound to COS cells expressing PLXND1, but not NRP1 or NRP2.72 AP‐SEMA3E bound to the blood vessels in sections from wild type but not PlnxD1 null embryos. Functional analysis showed that addition of SEMA3E caused collapse of PLXND1‐expressing COS cells. Unlike SEMA3D, SEMA3E‐mediated cytoskeletal reorganization does not require NRP1.68 Inactivation of PlxnD1 results in similar organizational defects in the somatic vasculature as observed in Sema3E‐null embryos.72The Role of SEMA5A During Cardiovascular DevelopmentSEMA5A is the only known member of the SEMA5 family for which there is clear genetic evidence to support its role during cardiovascular development. SEMA5A is a proangiogenic molecule that potently induces endothelial cell proliferation and migration and inhibits apoptosis.75, 76 Treatment of immortalized human dermal microvascular endothelial cells with SEMA5A significantly increased their migration. Furthermore, subcutaneous injection of SEMA5A‐containing matrigel enhanced blood vessel sprouting.75 Knocking out Sema5A in mice led to embryonic lethality between E11.5 and E12.5.77 A thorough examination of the cardiovascular system in mutants revealed that the number of secondary and tertiary branches of blood vessels in the cranial region was reduced, although the capillary network was not affected.77 No other cardiovascular defect was reported in mutant embryos. Therefore, the proangiogenic activity of SEMA5A is essential only in the cranial region in vivo. The major cause for the death of Sema5A‐null embryos remains unidentified, as the vascular defect in the cranial region is unlikely lethal to the embryo.The Role of Class 6 Semaphorins During Cardiovascular DevelopmentSEMA6A Role.In vitro analysis using human umbilical vascular endothelial cells showed that SEMA6A promotes endothelial cell survival and growth by modulating VEGFR2 signaling.78 The vascular defects in Sema6A‐null animals are limited to the eye. At the P4 stage, hyaloid vessels displayed a significantly reduced network complexity in mutant animals. Also at the same stage, the extension of the vascular network from the optic nerve to the periphery was also reduced in mutants. The vascular defects in eyes disappeared at the P8 stage.78 One likely reason is that other members of the semaphorin family are able to compensate for the loss of SEMA6A in mutant eyes at later stages. Sema3A is expressed in the vasculature of eyes during both embryonic and postnatal eye development79 and thus is a likely candidate.SEMA6A inhibits migration of NCCs isolated from Hamburger Hamilton 10 chicken embryos, in contrast to SEMA3C, which stimulates NCC migration.64 However, no defect was observed in the OFT and pharyngeal arch arteries in Sema6A‐null mice. It is thus possible that SEMA6A exerts different activities in chicken and mammals.SEMA6D Roles.The initial evidence indicating a role for SEMA6D during heart development came from chicken studies. It was found that SEMA6D could promote endocardial cell migration in the OFT region through the PLXNA1‐VEGFR2 receptor complex, whereas it inhibited endocardial cell migration in the ventricle region through the PLXNA1‐PTK7 receptor complex.18 In addition to acting on endocardial cells, SEMA6D can also regulate myocardial wall morphogenesis in chicken embryos through its cytoplasmic domain‐dependent reverse signaling.19 The chicken studies described above applied comprehensive loss‐of‐function and gain‐of‐function approaches; however, these activities of SEMA6D in chicken were not replicated in subsequent mouse studies.We recently developed a novel conditional immortal AV cushion mesenchymal cell line, tsA58‐AVM, and used this line to identify Sema6D as the regulatory target of bone morphogenetic protein signaling in AV cushions.80 Conditional inactivation of Sema6D in endocardial cells of mouse embryos using the Nfatc1‐Cre driver led to hypocellular AV cushions at E9.25 and E9.5 due to reduced EMT in the AV canal region. Functional tests revealed that SEMA6D activates Rho through PLXNA1‐FARP1 to promote cushion mesenchymal cell formation in the AV canal80 (Figure 2). Thus, EMT by endocardial cells in the OFT and AV canal both rely on semaphorin signaling, with the OFT region needing SEMA3C and the AV canal region requiring SEMA6D. The AV cushion defect in Nfatc1‐Cre/Sema6Dloxp/loxp embryos was resolved at a later stage (E10.5), likely due to the compensatory effect from increased expression of SEMA6C.80 Studies of double‐knockout mice of Sema6D and Sema6C are required to test this hypothesis. No defect in the OFT cushions or in the endocardial cells of ventricles was observed in Nfatc1‐Cre/Sema6Dloxp/loxp embryos.80 No myocardial wall defect was reported in Sema6D complete knockout mice.81 The apparent difference in the functions of SEMA6D between chicken studies and mouse studies suggests that this cytokine has differential roles in the cardiovascular system in birds and mammals.Download PowerPointFigure 2. SEMA6D promotes EMT at AV cushions. In responding to BMP ligands released from the overlying myocardium (such as BMP2 and BMP4), expression of SEMA6D in endocardial cells is upregulated in the AV canal region of mouse embryos at E9.0–9.5. SEMA6D acts on adjacent endocardial cells through the PLXNA1/FARP1/RHO axis to promote cushion mesenchymal cell formation and migration in AV cushions. AV indicates atrioventricular; BMP, bone morphogenic protein; EMT, epithelial‐mesenchymal transition.SummaryMultiple semaphorin molecules play an essential role in regulating cardiovascular development. This conclusion is supported by convincing mouse genetic evidence complemented with tests on other model systems including cell culture, zebrafish, and chicken studies (summarized in Table 2). The activities of semaphorin signaling are highly versatile and include regulation of NCC migration, endocardial cell EMT in the OFT and AV canal regions, cardiac innervation, myocardial wall morphogenesis, endothelial cell migration during blood vessel formation, and patterning of vessel networks.Table 2. Summary of Functions of Different Semaphorins During Cardiovascular DevelopmentSemaphorinsCardiovascular ExpressionCardiovascular Defects in MutantsSEMA3ATrabecular zone of embryonic hearts, Purkinje fiber, vascular endothelia cells52, 58Zebrafish: Abnormal dorsal aorta development59Mouse: sinus bradycardia, abrupt sinus slowing, stellate ganglia defects, right ventricle hypertrophy, abnormal patterning of anterior cardinal veins and intersomitic vessels52, 55, 58Human: Brugada syndrome56, 57SEMA3CNeural crest cells, outflow tract myocardial cells61, 62, 63, 65Mouse: interruption of the aortic arch, persistent truncus arteriosus, septation defects in the outflow tract61, 62, 63SEMA3DMesocardial reflection and proepicardial organ in embryos, neural crest cells70Zebrafish: dysmorphic hearts, absence of atrioventricular valves and trabeculation67Mouse: total anomalous pulmonary venous connection, cardiomegaly70Human: partial anomalous pulmonary venous connection, transposition of the great arteries, ventricular septal defect, coarctation of the aorta70, 71SEMA3ENotochord, lateral plate mesoderm, caudal region of somites72, 73Mouse: disorganized intersomitic vessels, paired dorsal aortas, fusion of a large plexus of blood vessels72, 73, 74SEMA5AAtrium septum, endocardial cells, cushion mesenchymal cells, mesoderm surrounding cranial vessels77Mouse: reduced number of secondary and tertiary branches of blood vessels in the cranial region77SEMA6AHyaloid vessels, retinal vessels78Mouse: reduced network complexity in hyaloid and retinal vessels at P4, defects resolved at P878SEMA6DMyocardial, endocardial, cushion mesenchymal cells18, 19, 80Chicken: altered endocardial cell migration, reduced myocardial wall trabeculation, small ventricle18, 19Mouse: reduced cushion mesenchymal cell number at E9.5, defect resolved at later stages80There remain some outstanding questions regarding the underlying mechanisms by which semaphorin signaling regulates cardiovascular development. We list 3 here. (1) The functions of semaphorins are highly cell‐type and/or tissue‐type dependent. In most cases it is unclear how such specificity is achieved. Detailed characterization of conditional gene‐inactivation mouse models, in which semaphorin/plexin genes are specifically inactivated in different cardiovascular cell types, would provide crucial clues to answer this question. (2) Semaphorins can activate many downstream effectors to accomplish their complex biological activities. Unlike many other signaling pathways, such as TGFβ/BMP signaling, there is no canonical pathway that is associated with semaphorin signaling. How the semaphorin/plexin complex on the cell surface selectively activates downstream cytoplasmic effectors in a context‐dependent fashion remains largely elusive. (3) Another critical question to be addressed is how semaphorin signaling interacts with other signaling pathways during cardiovascular development. Such interaction may occur at the cell surface through sharing (or competing for) the same coreceptors and/or in the cytoplasm through crosstalk between different cytoplasmic effectors.Answering the above questions will help us design effective strategies to accurately and specifically modulate semaphorin signaling for therapeutic purposes. Recent studies have shown that tumor angiogenesis can be regulated by different semaphorins.4, 82 A better understanding of the molecular mechanism by which semaphorins regulate blood vessel formation may lead to identification of novel intervention targets for cancer treatment. Another potential area for translational research of semaphorin signaling is regenerative medicine. For example, semaphorin signaling is involved in generation of cushion mesenchymal cells in both the OFT and AV canal regions. These mesenchymal cells are precursors of septa and valves in mature hearts. Our knowledge of semaphorin signaling during OFT and AV cushion development may provide crucial guidance for us to differentiate pluripotent stem cells into valvular/septal cells for tissue repair. This area of research remains a blank in the literature.In summary, semaphorins are versatile signaling molecules that regulate multiple aspects of cardiovascular development. Studies on semaphorin signaling are highly significant for both basic and translational research.AcknowledgmentsWe regret that due to space limitations, the work of all of our colleagues could not be cited here. We thank the members of the Jiao laboratory for their comments and suggestions for the article.Sources of FundingResearch in the authors’ laboratory is supported by NIH R01 (R01HL095783), R03 (R03HD082634), and R21 (R21CA199586) grants awarded to Jiao.DisclosuresNone.Footnotes*Correspondence to: Kexiang Liu, MD, Department of Cardiovascular Surgery, The Second Hospital of Jilin University, Changchun, China. E‐mail: [email protected]com or Kai Jiao, MD, PhD, Department of Genetics, The University of Alabama at Birmingham, AL. E‐mail: [email protected]eduReferences1 Tessier‐Lavigne M, Goodman CS. The molecular biology of axon guidance. Science. 1996; 274:1123–1133.CrossrefMedlineGoogle Scholar2 Tamagnone L, Artigiani S, Chen H, He Z, Ming GI, Song H, Chedotal A, Winberg ML, Goodman CS, Poo M, Tessier‐Lavigne M, Comoglio PM. Plexins are a large family of receptors for transmembrane, secreted, and GPI‐anchored semaphorins in vertebrates. Cell. 1999; 99:71–80.CrossrefMedlineGoogle Scholar3 Goodman C, Kolodkin A, Luo Y, Püschel A, Raper J. Unified nomenclature for the semaphorins/collapsins. Cell. 1999; 97:551–552.CrossrefMedlineGoogle Scholar4 Neufeld G, Mumblat Y, Smolkin T, Toledano S, Nir‐Zvi I, Ziv K, Kessler O. The semaphorins and their receptors as modulators of tumor progression. Drug Resist Updat. 2016; 29:1–12.CrossrefMedlineGoogle Scholar5 Gurrapu S, Tamagnone L. Transmembrane semaphorins: multimodal signaling cues in development and cancer. Cell Adh Migr. 2016; 10:675–691.CrossrefMedlineGoogle Scholar6 Kruger RP, Aurandt J, Guan KL. Semaphorins command cells to move. Nat Rev Mol Cell Biol. 2005; 6:789–800.CrossrefMedlineGoogle Scholar7 Suzuki K, Kumanogoh A, Kikutani H. Semaphorins and their receptors in immune cell interactions. Nat Immunol. 2008; 9:17–23.CrossrefMedlineGoogle Scholar8 Kang S, Kumanogoh A. Semaphorins in bone development, homeostasis, and disease. Semin Cell Dev Biol. 2013; 24:163–171.CrossrefMedlineGoogle Scholar9 Epstein JA, Aghajanian H, Singh MK. Semaphorin signaling in cardiovascular development. Cell Metab. 2015; 21:163–173.CrossrefMedlineGoogle Scholar10 Kolodkin AL, Matthes DJ, O'Connor TP, Patel NH, Admon A, Bentley D, Goodman CS. Fasciclin IV: sequence, expression, and function during growth cone guidance in the grasshopper embryo. Neuron. 1992; 9:831–845.CrossrefMedlineGoogle Scholar11 Siebold C, Jones EY. Structural insights into semaphorins and their receptors. Semin Cell Dev Biol. 2013; 24:139–145.Crossre